Aligos Therapeutics Inc (ALGS) — Financial Flexibility Index
Aligos Therapeutics Inc (ALGS) has a Financial Flexibility Index of -0.70x as of March 2026. Free cash flow of $-23.06 Million (operating CF $-23.13 Million minus capex $69.00K) represents -1% of total liabilities ($32.77 Million). Also explore Aligos Therapeutics Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aligos Therapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Aligos Therapeutics Inc across 8 annual periods. Check Aligos Therapeutics Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Aligos Therapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Aligos Therapeutics Inc. For the full company profile including market capitalisation, see Aligos Therapeutics Inc (ALGS) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.35x | $-82.07 Million | $-82.50 Million | $34.99 Million | ▼ -188.2% |
| 2024 | -0.81x | $-80.61 Million | $-80.74 Million | $99.07 Million | ▲ +38.8% |
| 2023 | -1.33x | $-78.98 Million | $-79.00 Million | $59.45 Million | ▲ +27.5% |
| 2022 | -1.83x | $-78.45 Million | $-79.39 Million | $42.79 Million | ▲ +19.1% |
| 2021 | -2.27x | $-114.77 Million | $-115.66 Million | $50.64 Million | ▼ -42.1% |
| 2020 | -1.60x | $-72.20 Million | $-74.26 Million | $45.26 Million | ▼ -666.7% |
| 2019 | -0.21x | $-43.98 Million | $-46.77 Million | $211.41 Million | ▼ -615.3% |
| 2018 | -0.03x | $-3.53 Million | $-6.05 Million | $121.48 Million | — |